CARE Ratings delivered robust financial results for the quarter ended March 2026, with consolidated net profit rising 23.98% to ₹52.83 crore compared to ₹42.61 crore in the corresponding quarter of the previous year. According to reports from Business Standard, the company's sales increased 19.17% to ₹130.67 crore in Q4 FY26, up from ₹109.65 crore in Q4 FY25. The strong performance was driven by improved operational efficiency and market demand for credit rating services.
For the complete financial year ended March 2026, CARE Ratings maintained its growth trajectory with net profit increasing 24.73% to ₹171.18 crore compared to ₹137.24 crore in the previous year. As reported by Business Standard, the company's annual sales grew 17.59% to ₹473.07 crore in FY26, up from ₹402.32 crore in FY25. The consistent growth across both quarterly and annual periods demonstrates the company's strong market position and operational excellence in the credit rating sector.
CARE Ratings shares surged 7.99% following the strong quarterly results announcement, reflecting positive investor sentiment toward the company's robust financial performance. The stock's performance was supported by the company's consolidated profit after tax of ₹52.83 crore in Q4 FY26, representing a 47.16% increase from ₹35.90 crore in Q3 FY26. The company's revenue from operations increased 19.17% year-on-year to ₹130.67 crore and rose 16.54% sequentially from ₹112.12 crore in the previous quarter, demonstrating strong operational momentum across multiple periods.
